Evidence map›Paper›PMID 39549198›Full record

ArticleGeroScience2025

The Multi-State Epigenetic Pacemaker enables the identification of combinations of factors that influence DNA methylation.

Colin Farrell, Keshiv Tandon, Roberto Ferrari, Kalsuda Lapborisuth, Rahil Modi, Sagi Snir, Matteo Pellegrini

Abstract read
In one paragraph

Article in GeroScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Embracing non-linearity in human ageing.Nature reviews. Genetics · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Colin FarrellDept. of Molecular, Cell and Developmental Biology, University of California, Los Angeles, 90095, CA, USA. colinpfarrell@gmail.com.
Keshiv TandonDept. of Molecular, Cell and Developmental Biology, University of California, Los Angeles, 90095, CA, USA.
Roberto FerrariDept. of Chemistry, Life Sciences and Environmental Sustainability, Laboratory of Molecular Cell Biology of the Epigenome (MCBE), University of Parma, Parma, Italy.
Kalsuda LapborisuthDept. of Molecular, Cell and Developmental Biology, University of California, Los Angeles, 90095, CA, USA.
Rahil ModiDept. of Molecular, Cell and Developmental Biology, University of California, Los Angeles, 90095, CA, USA.
Sagi SnirDept. of Evolutionary Biology, University of Haifa, Haifa, Israel.
Matteo PellegriniDept. of Molecular, Cell and Developmental Biology, University of California, Los Angeles, 90095, CA, USA. matteop@mcdb.ucla.edu.ORCID 0000-0001-9355-9564

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epigenetic clocks, DNA methylation-based predictive models of chronological age, are often utilized to study aging associated biology. Despite their widespread use, these methods do not account for other factors that also contribute to the variability of DNA methylation data. For example, many CpG sites show strong sex-specific or cell-type-specific patterns that likely impact the predictions of epigenetic age. To overcome these limitations, we developed a multidimensional extension of the Epigenetic Pacemaker, the Multi-state Epigenetic Pacemaker (MSEPM). We show that the MSEPM is capable of accurately modeling multiple methylation-associated factors simultaneously, while also providing site-specific models that describe the per site relationship between methylation and these factors. We utilized the MSEPM with a large aggregate cohort of blood methylation data to construct models of the effects of age-, sex-, and cell-type heterogeneity on DNA methylation. We found that these models capture a large faction of the variability at thousands of DNA methylation sites. Moreover, this approach allows us to identify sites that are primarily affected by aging and no other factors. An analysis of these sites reveals that those that lose methylation over time are enriched for CTCF transcription factor chip peaks, while those that gain methylation over time are associated with bivalent promoters of genes that are not expressed in blood. These observations suggest mechanisms that underlie age-associated methylation changes and suggest that age-associated increases in methylation may not have strong functional consequences on cell states. In conclusion, the MSEPM is capable of accurately modeling multiple methylation-associated factors, and the models produced can illuminate site-specific combinations of factors that affect methylation dynamics.

Indexed as

AgingDNA MethylationEpigenesis, GeneticAdultAgedAged, 80 and overCpG IslandsFemaleHumansMaleMiddle Aged

Identifiers

PMID39549198
PMCPMC11979089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.